FAA clarifies diabetes and neurofibromatosis workflows in AME guide

Feb 27, 2026

FAA updated AME guide language to rename diabetes/hyperglycemia worksheets to include injectable GLP-1 agents (non-insulin injectables) and clarified that insulin use triggers a separate workflow; it also moved neurofibromatosis type 1 to an AASI with a neurologist progress note current within 90 days.

The full story

The Federal Aviation Administration clarified two noncardiac medical-workflow updates for Aviation Medical Examiners during the January Grand Rounds.

Free newsletter

Sign up to keep reading.

Your free newsletter brings you what your city council, county, and school board discussed and decided.

or
Already have an account? Sign in